Skip to main content

Doximity buys Pathway Medical for $63M

By CNBC  
   August 10, 2025

Doximity is diving deeper into artificial intelligence, announcing on Thursday the acquisition of startup Pathway Medical for $63 million. Pathway has built an AI-powered clinical reference tool that doctors can use to ask questions about guidelines, drugs and trials. Pathway's answers are synthesized from medical literature, and Doximity said the Montreal-based startup has one of the largest structured datasets in medicine. 

Full story


Get the latest on healthcare leadership in your inbox.